West Pharmaceutical Services Financial Ratios
NYSE: WSTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
West Pharmaceutical Services ratio analysis
West Pharmaceutical Services earned a net margin of 16.1% in FY 2025, down from 17.0% a year earlier. Gross margin was 35.9% compared with a median of 34.5% over the prior 9 years. Return on equity reached 15.5%, meaning West Pharmaceutical Services generated 0.16 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.06 versus 0.08 the year before, and the current ratio was 3.02. At the end of FY 2025, WST traded at 40.7 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 30.4 to 62.0, with a median of 46.0. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
West Pharmaceutical Services financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 40.71 | 50.16 | 44.69 | 30.45 | 54.10 | 61.99 | 47.40 | 35.85 | 49.58 | 44.41 |
| Price / sales | 6.50 | 8.47 | 8.87 | 6.07 | 12.32 | 9.75 | 6.12 | 4.23 | 4.56 | 4.12 |
| Price / book | 6.29 | 9.13 | 9.08 | 6.52 | 14.94 | 11.29 | 7.16 | 5.20 | 5.70 | 5.56 |
| Gross margin | 35.9% | 34.5% | 38.3% | 39.4% | 41.5% | 35.8% | 32.9% | 31.8% | 32.1% | 33.2% |
| Operating margin | 19.0% | 19.7% | 22.9% | 25.4% | 26.6% | 19.0% | 16.1% | 14.0% | 14.1% | 12.9% |
| Net margin | 16.1% | 17.0% | 20.1% | 20.3% | 23.4% | 16.1% | 13.1% | 12.0% | 9.4% | 9.5% |
| Free cash flow margin | 15.3% | 9.6% | 14.1% | 15.2% | 11.7% | 13.9% | 13.1% | 10.7% | 8.3% | 3.3% |
| Return on equity (ROE) | 15.5% | 18.4% | 20.6% | 21.8% | 28.3% | 18.7% | 15.4% | 14.8% | 11.8% | 12.9% |
| Return on assets (ROA) | 11.6% | 13.5% | 15.5% | 16.2% | 20.0% | 12.4% | 10.3% | 10.5% | 8.1% | 8.4% |
| Debt / equity | 0.06 | 0.08 | 0.07 | 0.08 | 0.11 | 0.14 | 0.16 | 0.14 | 0.15 | 0.20 |
| Current ratio | 3.02 | 2.79 | 2.88 | 3.70 | 2.93 | 2.73 | 3.10 | 3.15 | 2.66 | 2.66 |
| Revenue growth | 6.3% | -1.9% | 2.2% | 2.0% | 31.9% | 16.7% | 7.1% | 7.4% | 6.0% | 7.8% |
| EPS growth | 1.5% | -15.1% | 1.9% | -10.8% | 89.7% | 42.4% | 17.2% | 37.7% | 4.2% | 46.9% |